|
Real-time Estimate
Cboe BZX
15:54:36 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 2.095 USD | +1.45% |
|
-3.27% | -39.89% |
| 08-24 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 08-13 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.45% | -3.27% | -1.90% | -17.14% | -39.89% | -31.20% | -20.31% | -80.74% | -97.41% | 43.44M | |
| +4.16% | +4.16% | +8.78% | +36.08% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.69B | |
| +0.46% | -1.16% | -6.15% | +3.15% | +16.99% | +23.36% | +79.34% | +230.03% | +5,457.32% | 58.81B | |
| +0.17% | +0.35% | +2.96% | +0.49% | +7.33% | +6.85% | +34.55% | -17.16% | +211.16% | 48.45B | |
| +0.64% | -2.52% | -3.49% | +5.05% | +151.20% | +329.63% | +685.55% | +618.42% | - | 42.84B | |
| -0.59% | -4.13% | -0.57% | +23.78% | +14.34% | +28.32% | +29.17% | +5.71% | +224.36% | 42.79B | |
| +0.27% | -0.83% | +3.25% | +17.46% | +19.45% | +6.23% | +110.02% | +0.80% | +1,039.73% | 41.25B | |
| -0.11% | +1.96% | -3.03% | +3.70% | +5.81% | +9.19% | +52.66% | +4.65% | +144.87% | 31.13B | |
| -2.07% | +1.16% | +16.96% | +54.16% | +80.34% | +35.00% | +26.28% | -52.35% | - | 30.28B | |
| -0.27% | -2.63% | -2.99% | +1.51% | +0.54% | -9.76% | -12.44% | -61.18% | - | 24.05B | |
| -3.18% | -10.68% | -18.36% | -9.65% | -41.42% | -37.19% | +315.97% | +269.27% | +599.76% | 22.98B | |
| +0.20% | +6.15% | +16.16% | +31.14% | +22.69% | +18.82% | +2.05% | -11.37% | +118.93% | 22.35B | |
| +0.00% | -3.85% | +1.57% | +9.86% | +6.86% | +12.84% | +142.05% | +210.71% | +1,886.64% | 16.83B | |
| -1.26% | -1.67% | -10.31% | -9.80% | +177.32% | +133.17% | +348.50% | +1,873.29% | +667.33% | 15.32B | |
| -2.09% | -13.80% | +9.81% | +17.49% | +19.56% | -24.09% | - | - | - | 12.99B | |
| +1.26% | -0.52% | -16.08% | -15.10% | - | - | - | - | - | 14.85B | |
| -1.51% | +2.19% | +7.38% | +31.83% | +51.13% | +77.23% | +56.14% | -27.63% | +263.04% | 14.56B | |
| +0.50% | +0.42% | +5.23% | +11.38% | +22.63% | +23.14% | +44.54% | -28.79% | +86.13% | 14.89B | |
| +0.09% | +0.17% | +1.46% | +2.51% | +33.49% | +47.64% | +172.27% | +171.38% | +351.81% | 14.45B | |
| -1.97% | -3.78% | -4.45% | -8.83% | +19.48% | -18.86% | +516.58% | - | - | 14.56B | |
| Average | -0.25% | -1.15% | +0.31% | +9.45% | +34.34% | +35.77% | +148.73% | +183.21% | +842.59% | 27.91B | |
| Weighted average by Cap. | +0.22% | -0.88% | +1.04% | +13.76% | +41.75% | +46.91% | +145.57% | +149.46% | +1,328.43% |
- Stock Market
- Stocks
- GRCE Stock
- Sector Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
